John Serio featured in Medtech Insight's "FDA Wants To Make Permanent COVID-19 Supply Chain Guidance To Prevent Product Shortages"

14 January 2022 | Applicable law: US

John Serio was featured in the article, ‘FDA Wants To Make Permanent COVID-19 Supply Chain Guidance To Prevent Product Shortages,’ which was published by Medtech Insight on January 11, 2022. The article discusses the US Food and Drug Administration’s push to keep a guidance in place that requires medtech manufacturers and distributors to notify the agency of a product shortage during a public health emergency.

John Serio, shares that “the guidance allows companies and the FDA to work together to prevent shortages of critical medical products in future health emergencies and suggests that those that don’t company by penalized.” “What the agency wants to be able to do in responding to emergencies is make sure that in the event a manufacturer is having a supply problem, a regulatory problem, whatever problem, that they can then prioritize maybe inspections of other plants, approvals of other regulatory applications, to address the gap of a discontinuance of a medical device.

Click here to view the full article

This document (and any information accessed through links in this document) is provided for information purposes only and does not constitute legal advice. Professional legal advice should be obtained before taking or refraining from any action as a result of the contents of this document.


Related experience

As a full-service law firm, we are able to provide advice and information about a wide range of other issues. Here are some related areas.

Join the club

We have lots more news and information that you'll find informative and useful. Let us know what you're interested in and we'll keep you up to date on the issues that matter to you.